Selcox Capsule 200mg (Celecoxib)

Adult dose

The minimum recommended dose of this medicine should be adjusted for each patient, and it may be taken with or without food. ○ Adults: 1. Osteoarthritis (degenerative arthritis): Take celecoxib 200 mg once daily, or 100 mg twice daily in divided doses. 2. Rheumatoid arthritis: Take celecoxib 100 mg or 200 mg twice daily. 3. Ankylosing spondylitis (AS): Administer celecoxib 200 mg once daily, or 100 mg twice daily in divided doses. If no effect is observed after 6 weeks, a dose of up to 400 mg daily may be administered. If no effect is observed after 6 weeks of treatment with 400 mg daily, consider another treatment option. 4. Acute pain and primary dysmenorrhea: The recommended initial dose is celecoxib 400 mg; an additional 200 mg may be given on the first day of treatment if needed. From the second day of treatment, the recommended dose, if needed, is 200 mg twice daily. ○ Patients with hepatic impairment: In patients with moderate hepatic impairment (Child-Pugh Class II), the dose should be reduced to approximately 50% of the recommended daily dose.

This medication should be used cautiously in individuals who consume excessive alcohol daily as it may increase the risk of gastrointestinal bleeding; medical consultation is necessary. This medication can cause cardiovascular issues, increasing the risk of heart attack or stroke; thus, it should be used at the lowest effective dose and for the shortest duration. Severe gastrointestinal issues such as perforation, ulcers, and bleeding may occur, especially in patients with a history of gastrointestinal disorders or the elderly. Patients with allergies to this medication, certain liver, kidney, or heart diseases, pregnant or breastfeeding women, and patients with inflammatory bowel disease should not take it. Patients with weakened liver or kidney function, as well as those with asthma, hypertension, and heart failure should use this medication cautiously and require regular monitoring. Dizziness or drowsiness may occur while taking this medication, so driving or operating machinery should be avoided. Due to potential interactions with other drugs, especially those metabolized by the liver, dose adjustments and caution are required when taken with other medications. It may be harmful to the fetus, especially in the later stages of pregnancy; thus, it should be avoided in women who could become pregnant, and it should be discontinued immediately if pregnancy is confirmed. Long-term use requires regular blood tests and liver, kidney function tests, and any unusual symptoms should be reported to a doctor immediately. Overdose may result in nausea, vomiting, drowsiness, or gastrointestinal bleeding; immediate medical attention is required. It is advisable to avoid use in children and adolescents as safety and efficacy have not been established. This medication should be kept out of the reach of children and should not be transferred to other containers for safety.

Gastrointestinal bleeding, cardiovascular thrombotic reactions, myocardial infarction, stroke, perforation of the upper and lower gastrointestinal tract, ulcers, bleeding, bronchitis, sinusitis, upper respiratory tract infections, urinary tract infections, pharyngitis, rhinitis, anemia, thrombocytopenia, hypersensitivity, insomnia, anxiety, confusion, dizziness, muscle hypertonicity, drowsiness, blurred vision, tinnitus, palpitations, congestive heart failure, arrhythmia, tachycardia, hypertension, flushing, cough, vomiting, abdominal pain, diarrhea, dyspepsia, abdominal distension, gastric ulcer, dental diseases, duodenal ulcer, esophageal ulcer, intestinal perforation, pancreatitis, elevated liver enzymes, pruritus, rash, urticaria, petechiae, angioedema, alopecia, dermatitis herpetiformis, peripheral edema, facial edema, influenza-like illness, damage, headache, leg cramps, hypertonicity, sensory impairment, migraine, neuralgia, neuropathy, sensory anomalies, cerebral infarction, aseptic meningitis, ataxia, suicide, anosmia, ageusia, allergy exacerbation, allergic reaction, weakness, chest pain, fluid retention, systemic edema, facial swelling, fatigue, lethargy, fever, facial flushing, influenza syndrome, pain, peripheral pain, sepsis, sudden death, anaphylactoid reaction, vasculitis, thrombotic venous inflammation, deep vein thrombosis, cerebral hemorrhage, wound infection, gingivitis, herpes simplex, shingles, bacterial infections, fungal infections, soft tissue infections, viral infections, moniliasis, genital moniliasis, otitis media, breast tenderness, menopausal symptoms, fibrocystic breast disease, thoracic neoplasm, dysmenorrhea, menstrual disorders, vaginal bleeding, vaginitis, prostate disorders, ovarian cysts, hearing loss, ear abnormalities, otalgia, hearing impairment, liver dysfunction, elevated ALT, elevated AST, increased γ-GTP, increased ALP, positive urobilinogen, cholelithiasis, hepatitis, jaundice, liver failure, fulminant hepatitis, hepatic necrosis, elevated blood sodium, elevated blood potassium, increased BUN, increased CPK, diabetes, hypercholesterolemia, hyperglycemia, hypokalemia, hyperkalemia, increased NPN, increased creatinine, increased alkaline phosphatase, weight gain, appetite loss, increased LDH, hypoglycemia, hyponatremia, bursitis, arthralgia, arthropathy, skeletal abnormalities, myalgia, cervical dystonia, synovitis, tendinitis, myositis, fractures, tendon rupture, reduced hematocrit, increased hemoglobin, petechiae, epistaxis, thrombocytopathy, agranulocytosis, aplastic anemia, pancytopenia, leukopenia, vasculitis, contact dermatitis, injection site reactions, skin nodules, ageusia, albuminuria, cystitis, hematuria, dysuria, frequent urination, nephrolithiasis, urinary incontinence, blurred vision, cataracts, conjunctivitis, ocular pain, glaucoma, ocular hemorrhage, retinal artery or vein occlusion, renal dysfunction, acute renal failure, interstitial nephritis, menstrual disorders, chest pain, anaphylactic reaction, hallucinations, cerebral hemorrhage, aseptic meningitis, ageusia, anosmia, conjunctivitis, pulmonary embolism, interstitial pneumonia, gastrointestinal bleeding, hepatitis, photosensitivity reactions, Stevens-Johnson syndrome, erythema multiforme, toxic epidermal necrolysis, drug rash, acute generalized rash with pustules, exfoliative dermatitis, acute renal failure, hyponatremia, tubular interstitial nephritis, nephrotic syndrome, minimal change disease nephritis, female infertility

This medication should be stored in an airtight, sealed container and kept at room temperature between 15°C and 30°C. Proper storage will help maintain the medication's effectiveness.

Appearance

A white capsule filled with a white to light yellow powder, featuring yellow stripes on the top and bottom.

Package unit

30 capsules/bottle, 100 capsules/bottle